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The National Health Service is the principal
provider of free healthcare services, through
general practitioners offering primary care to a
network of District and Regional or University
Teaching hospitals.  Medical Genetics has a long
history in the UK, although it was not recognised
formally until the 1970s.  Regional Genetics
Centres, providing an integrated clinical and
laboratory service, have been established for
many years.  Most also operate “outreach” clinics
at satellite hospitals, or dedicated joint specialist
clinics.  There are 25 Regional Genetics Centres,
each serving a population of 3–6 million: in 1997
they had 79 specialist clinicians (with 55
trainees), and 107 Genetic Counsellors.
Genetic counselling is offered by Consultant
Clinical Geneticists (with specialist training),
supported by Specialist Registrars in Clinical
Genetics and Genetic Nurses or Counsellors.
Since the 1970s the UK has had several
counsellors attached to each Regional Genetics
Centre.  In many centres they provide full genetic
counselling for many conditions, with the support
of a discussion departmental framework.  Genetic
Counsellors are valuable members of the clinical
genetics team, who play a considerable role in the
provision of counselling service, thereby
reducing the workload of Consultants and
Registrars, who can then target particular aspects
of the service.
Laboratory diagnostic services are integral
parts of the Regional Genetics Centres.  In 1997
there were 408 cytogeneticists (with 106 trainees)
and 101 molecular geneticists (with 31 trainees).
There is now a clear process of laboratory
accreditation.  The UK network of molecular
genetics centres has rationalised testing for
mutations in specific genes in certain centres
only, by agreement.  However, the patenting of
genes such as BRCA1 and BRCA2 is likely to
have a profound impact on the costs and
management of cancer services, and could result
in “rationing” of tests to very high-risk families
only.
CANCER GENETICS SERVICES
Cancer genetics referrals have increased greatly
over the last ten years, and now comprise
approximately half of the genetics referrals in many
centres.  The Department of Health commissioned a
recent review of cancer genetics services from a
working group under Prof. Peter Harper [1].  The
report of this group has stimulated negotiations to
increase funding for cancer genetics services.  A
similar report was published in 1998 by the Scottish
Office (Department of Health), covering Cancer
Genetics Services in Scotland.  Both reports
recommend the establishment of Regional Cancer
Genetics Centres, offering services on the basis of
agreed risk criteria (judged by family history).
Currently, most specialised genetic counselling
for familial cancer is organised by the Regional
Genetic Centres.  Most run designated Cancer
Family Clinics, or operate multi-disciplinary clinics
in conjunction with other specialties. Initially many
of these were developed on an ad hoc basis, funded
from research sources, but NHS funding is now
replacing this.  The service is becoming more
integrated and cohesive with the benefit of
discussion fora such as the Cancer Family Study
Group, and management guidelines are being
developed.  In addition, it is increasingly being
recognised that general practitioners and specialists
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in other disciplines have an important role to play in
the initial recognition of patients and families in
need of referral for specialist genetic counselling.  It
is intended that specialised cancer care be
centralised to the specialist units dealing with the
care of breast/ colorectal cancer etc., each catering
for some 150,000–250,000 people, according to
guidelines laid out in the Calman–Hine Report
(1995). Individuals at moderately increased risk
will be managed in this way, and only high-risk
individuals in whose families it is probable that a
genetic predisposition is segregating will be seen in
the Regional Genetics Centres themselves (serving
a population of 3–6 million).  Genetic Counsellors
will play an important role in evaluating risks for
prioritising referrals, and coordinating screening.
They are also likely to provide a “gatekeeper” role
in primary care.
Audited follow-up is crucial for evidence-based
review, facilitated by a fully-documented confi-
dential database recording pedigree data and
surveillance outcomes.  This requires dedicated data
managers, and preferably a coordinated surveillance
network.  Specialised genetic counsellors might
also fill this role.
The Royal College of General Practitioners is
currently debating ways of improving education for
primary care practitioners, and various other
organisations are involved in educational initiatives
(for instance, the Genetic Interest Group).
TRAINING OF CANCER
GENETICISTS
• Accreditation of oncologists (and specialists
from related disciplines) and clinical
geneticists in Cancer Genetics is currently
being considered by the Royal Colleges, and
the appropriate training for specialist
registrars in oncology and genetics wishing
to be accredited in cancer genetics is under
consideration by the relevant Specialist
Advisory Committees.
• The Harper Report emphasised the need to
build up expertise at the level of the Calman
Centres, which will provide specialised
cancer care, under the direction of the
Regional Genetics Centre.
Discussion fora:
• The British Society of Human Genetics
(formed in 1996) is made up of the Clinical
Genetics Society, the Association of
Clinical Cytogenetics, the Clinical
Molecular Genetics Society and the Genetic
Nurses & Social Workers Association.
• Cancer Family Study Group
• National Cancer Forum
• ICRF Cancer Genetic Nurse Support Group
• Northern Ireland Regional Advisory
Committee on Cancer
A number of cancer and genetic registries
exist.  Many Regional Genetics Centres have
registries for specific genetic conditions,
including some monogenic cancer-predisposing
conditions.
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